Your browser doesn't support javascript.
loading
Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1.
Uraki, Ryuta; Ito, Mutsumi; Kiso, Maki; Yamayoshi, Seiya; Iwatsuki-Horimoto, Kiyoko; Sakai-Tagawa, Yuko; Furusawa, Yuri; Imai, Masaki; Koga, Michiko; Yamamoto, Shinya; Adachi, Eisuke; Saito, Makoto; Tsutsumi, Takeya; Otani, Amato; Kashima, Yukie; Kikuchi, Tetsuhiro; Yotsuyanagi, Hiroshi; Suzuki, Yutaka; Kawaoka, Yoshihiro.
Afiliação
  • Uraki R; Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
  • Ito M; Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Kiso M; Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Yamayoshi S; Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
  • Iwatsuki-Horimoto K; Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Sakai-Tagawa Y; Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Furusawa Y; Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
  • Imai M; Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
  • Koga M; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Yamamoto S; Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Adachi E; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Saito M; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Tsutsumi T; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Otani A; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Kashima Y; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Chiba, Japan.
  • Kikuchi T; Clinic of Nihon Sumo Kyokai, Tokyo, Japan.
  • Yotsuyanagi H; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Suzuki Y; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Chiba, Japan.
  • Kawaoka Y; Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, Japan; Influenza Research Institute, Department of Pathobiological Sciences, School of Veter
Lancet Infect Dis ; 23(5): 525-526, 2023 05.
Article em En | MEDLINE | ID: mdl-36898405
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Fármacos Dermatológicos / COVID-19 Limite: Humans Idioma: En Revista: Lancet Infect Dis Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Fármacos Dermatológicos / COVID-19 Limite: Humans Idioma: En Revista: Lancet Infect Dis Ano de publicação: 2023 Tipo de documento: Article